Lanthanum Cation (3+): Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Lanthanum Cation (3+). Educational only — not medical advice.
Labeled uses
Lanthanum carbonate chewable tablets are a phosphate binder indicated to reduce serum phosphate in patients with end-stage renal disease (ESRD). Management of elevated serum phosphorus levels in patients with ESRD usually includes all of the following: reduction in dietary intake of phosphate, removal of phosphate by dialysis, and reduction of intestinal phosphate absorption with phosphate binders.
Source: FDA labeling via NIH DailyMed (set e4b88992…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.